Monitoring Hepatocellular Carcinoma Using Tumor Content in Circulating Cell-Free DNA

Scientists evaluated the utility of tumor content in circulating cell-free DNA for monitoring HCC throughout its natural history. They included 67 hepatitis B virus-related HCC patients, of whom 17 had paired pre- and post-treatment samples, and 90 controls.